Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 10
Submit an article Journal homepage
29
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia

Shelby D. Reed Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina; Department of Medicine, Duke University Medical Center, Durham, North Carolina
,
Jasmina I. Radeva Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina
,
Davey B. Daniel Department of Medicine, Duke University Medical Center, Durham, North Carolina
,
John M. Fastenau Clinical Affairs, Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey
,
Denise Williams Clinical Affairs, Ortho Biotech Clinical Affairs, LLC, Bridgewater, New Jersey
&
Kevin A. Schulman Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Durham, North Carolina; Department of Medicine, Duke University Medical Center, Durham, North CarolinaCorrespondence[email protected]
Pages 1527-1533 | Accepted 05 Aug 2005, Published online: 31 Aug 2005

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Frank J Papatheofanis. (2007) Comparative costs of treatment with epoetin alfa and darbepoetin alfa for anemia in the oncology and nephrology settings. Expert Review of Pharmacoeconomics & Outcomes Research 7:1, pages 59-73.
Read now
David H. Henry, Lucio N. Gordan, Veena Charu, Francois E. Wilhelm, Denise Williams, John Xie & Richard C. Woodman. (2006) Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia. Current Medical Research and Opinion 22:7, pages 1403-1413.
Read now

Articles from other publishers (10)

Louise Crathorne, Nicola Huxley, Marcela Haasova, Tristan Snowsill, Tracey Jones-Hughes, Martin Hoyle, Simon Briscoe, Helen Coelho, Linda Long, Antonieta Medina-Lara, Ruben Mujica-Mota, Mark Napier & Chris Hyde. (2016) The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model. Health Technology Assessment 20:13, pages 1-588.
Crossref
L. Boulaamane, A. Goncalves, S. Boutayeb, P. Viens, H. M’rabti, F. Bertucci & H. Errihani. (2013) Prognostic impact of the combination of erythropoiesis-stimulating agents to cancer treatment: literature review. Supportive Care in Cancer 21:8, pages 2359-2369.
Crossref
Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert & Julia Bohlius. (2012) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database of Systematic Reviews.
Crossref
M Aapro, W Jelkmann, S N Constantinescu & B Leyland-Jones. (2012) Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. British Journal of Cancer 106:7, pages 1249-1258.
Crossref
Julia Bohlius, Kurt Schmidlin, Corinne Brillant, Guido Schwarzer, Sven Trelle, Jerome Seidenfeld, Marcel Zwahlen, Mike J Clarke, Olaf Weingart, Sabine Kluge, Margaret Piper, Maryann Napoli, Dirk Rades, David Steensma, Benjamin Djulbegovic, Martin F Fey, Isabelle Ray-Coquard, Volker Moebus, Gillian Thomas, Michael Untch, Martin Schumacher, Matthias Egger & Andreas Engert. (2009) Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews.
Crossref
José Luis Pontón Sivillá, Evaristo Feliu Frasnedo, Pilar Modamio Charles, Eduardo L. Mariño Hernández, Albert Font Pous, Clara Lezcano Rubio, José María Ribera Santasusana & Xavier Bonafont Pujol. (2008) Estudio de la efectividad de tres esquemas de administración de factores estimuladores de la eritropoyesis en pacientes con anemia asociada a quimioterapia por una neoplasia sólida o hematologica. Medicina Clínica 131:12, pages 447-451.
Crossref
David H. Henry. (2008) Extended-dosing epoetin alfa for chemotherapy-induced anemia: focus on elderly breast and colorectal cancer patients. Community Oncology 5:6, pages 310-321.
Crossref
Bonne Biesma, Paul R. van de Werf, Christian F. Melissant & Ronald G.P.M. Brok. (2007) Anaemia management with epoetin alfa in lung cancer patients in The Netherlands. Lung Cancer 58:1, pages 104-111.
Crossref
Carsten Oberhoff. (2007) Speed of haemoglobin response in patients with cancer: a review of the erythropoietic proteins. Supportive Care in Cancer 15:6, pages 603-611.
Crossref
Roger Waltzman. (2006) In Reply. The Oncologist 11:5, pages 536-537.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.